Free Carrying!

For once, I totally agree with Gassy regarding individuals who have started to unwind some of their parcels and will 'free carry' until the results are published in early or late July 2017. As I correctly predicted last week, expect Innate to drift towards A$.60/share over the next couple of weeks. I have talked with 3 individuals that purchased at A$.25 per share that are cashing in on their initial investments and letting their profits roll into the results. In addition, the reason I feel that the USA OTC market has stayed relatively stable is the fact that the majority of those mates are ones that got in above US$.70 per share or higher and they have no profits to show to date (like Jennifer). In summary, the key to everything with this company is one individual... Dr. Peach! I truly believe that he would not be on the board and recently presented a poster in Boston USA if MIS416 did not indeed work. This big question is how effective was it during Phase 2B trials. We will all find out very soon.